Emend Intravenous and Luxiq
Determining the interaction of Emend Intravenous and Luxiq and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: fosaprepitant
Brand name: Emend for Injection
Synonyms: Fosaprepitant
Generic Name: betamethasone topical
Brand name: Diprolene, Luxiq, Sernivo, Diprosone, Uticort, Betanate, Alphatrex, Del-Beta, Maxivate, Valisone, Beta-Val, Betatrex, Betaderm, Diprolene AF, Teladar
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Emend Intravenous-Lybrel
- Emend Intravenous-Lyderm
- Emend Intravenous-Lydia E. Pinkham
- Emend Intravenous-Lyme disease vaccine (recombinant ospa) Intramuscular
- Emend Intravenous-Lymepak
- Emend Intravenous-Lymphocyte immune globulin, anti-thymocyte equine
- Luxiq-Emflaza
- Luxiq-Emflaza (Deflazacort Oral Suspension)
- Luxiq-Emflaza (Deflazacort Tablets)
- Luxiq-Emicizumab
- Luxiq-Emicizumab-kxwh
- Luxiq-Emicizumab-kxwh Subcutaneous